It works by mimicking a hormone called GLP-1 (glucagon-like peptide-1), which helps regulate blood sugar levels, reduces appetite, and slows down digestion
Missing doses during titration may cause temporary return of appetite and reduced efficacy until the next administration
[5] [3] Otros riesgos importantes incluyen enfermedad de la vescula biliar, lesin renal aguda debido a deshidratacin, y riesgo de hipoglucemia cuando se usa con insulina o sulfonilureas
*Correspondence: Vincenzo Triggiani, [email protected] This article was submitted to Clinical Diabetes, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Other factors within our body, like stomach acidity, physical activity, and stress levels, all come into play
While various risk factors for enhanced APAP toxicity have emerged in the numerous experimental models of steatosis, including induction of Cyp2E1, reduced phase II metabolism, mitochondrial dysfunction, etc., opposite effects have also been described, suggesting that steatosis may not affect toxicity [180]